---
title: "Xenon Pharmaceuticals director Steven Gannon disposes of 10,000 common shares for $640,550"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295844352.md"
description: "Xenon Pharmaceuticals director Steven Gannon sold 10,000 common shares on August 11, 2026, at a weighted-average price of $64.06 per share, totaling approximately $640,550. Following this transaction, his direct holding decreased to 1,870 common shares."
datetime: "2026-08-13T20:42:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295844352.md)
  - [en](https://longbridge.com/en/news/295844352.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295844352.md)
generator: "portal-rs"
---

# Xenon Pharmaceuticals director Steven Gannon disposes of 10,000 common shares for $640,550

-   Xenon Pharmaceuticals director Steven Gannon sold 10,000 common shares on Aug. 11, 2026 at a weighted-average price of $64.06. \* Gannon’s direct holding fell to 1,870 common shares following the sale. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xenon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-349351), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [XENE.US](https://longbridge.com/en/quote/XENE.US.md)

## Related News & Research

- [Xenon Pharmaceuticals (NASDAQ:XENE) Insider Sells $425,847.00 in Stock](https://longbridge.com/en/news/297641840.md)
- [Xenon grants 13,450 inducement stock options, 7,850 RSUs to new hires at $61.93 strike](https://longbridge.com/en/news/297363902.md)
- [eDreams Odigeo buys back 60,000 shares at average price EUR 5.51 under stabilization program](https://longbridge.com/en/news/297501270.md)
- [Safilo liquidity contract buys 1.62 million shares in August at avg price EUR 1.91](https://longbridge.com/en/news/297929865.md)
- [Xeris Biopharma CFO Steven Pieper disposes of 5,000 shares worth $42,500](https://longbridge.com/en/news/297704175.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**